NIBRT adds Modular Station to Bioprocessing Facilities

News

NIBRT adds Modular Station to Bioprocessing Facilities

24 Mar, 2015

Published over 11 years ago. See the latest and most current information on News.

A new generation isolator at the National Institute for Bioprocessing Research and Training (NIBRT), Dublin, is assisting with continual professional development at this leading institute for the life sciences industry.

The new system, a bespoke Qube M19 four-glove aseptic workstation with two glove separated decontamination unit and a material transfer device was installed at NIBRT’s fill-finish lab by Bioquell. It is fully integrated with rapid hydrogen peroxide vapour (HPV) decontamination to deliver ISO5 / Grade A conditions.

Michael Wood, Bioquell Ireland’s Life Sciences Sales Representative, said, “The training courses provided at NIBRT are an excellent insight into the biopharma industry. The Institute is an exceptional facility hosting the latest in biopharma technology. Bioquell is delighted to sponsor the installation of the Qube at NIBRT and we look forward to introducing new Bioquell technologies to NIBRT in the coming years.”

Commenting on the relationship with Bioquell, NIBRT’s Director of Projects, Killian O’Driscoll remarked “NIBRT is delighted to be partnering with Bioquell on their innovative Qube M19 technology which will further enhance NIBRT’s ability to provide market leading training and research solutions to our biopharma clients”

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
New laser-based PPM gas analysis for environmental monitoring
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
Three generations of innovation. One powerful new platform
Explore more Arrow
Chromatography Today
Wiley expands forensic drug database for faster identification of designer drugs
Explore more Arrow